Medical Tech

Nano-Engineered Brain Cancer Treatment Might Kill Tumor Cells and Activate Immune System
Medical Tech, University of Michigan

Nano-Engineered Brain Cancer Treatment Might Kill Tumor Cells and Activate Immune System

A new nanomedicine out of the University of Michigan uses a protein that crosses the blood-brain barrier carrying a drug that kills tumor cells and another drug that activates the immune system to fight brain cancer. That’s the news along with an announcement of $2.38 million to test the new cancer treatment in mice in Ann Arbor. The new medicine is targeting the most aggressive form of brain cancer, glioblastoma. The funding comes from the National Institutes of Health to test the technology at the University of Michigan.

Ann Arbor Continues Trajectory to HealthTech Startup Hub with New Crop of 2022 Companies
Medical Tech

Ann Arbor Continues Trajectory to HealthTech Startup Hub with New Crop of 2022 Companies

Ann Arbor continues to pump out new tech startups by the month, and we’ve got a sneak peek for 2022 on one of the fastest growing in health tech, who seemingly popped out of nowhere in 2021. Ripple Science, a new health tech startup that created a platform for recruiting and retaining patients for clinical trials, has already had significant product adoption by top universities like Cornell, Vanderbilt, Georgetown, John Hopkins and many more.

Ann Arbor’s Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech
Funding, Medical Tech

Ann Arbor’s Asalyxa Bio Raises $2 Million To Start Clinical Trials for Neutrophil-Targeting Drug Delivery Tech

Asalyxa Bio, Inc., a biopharmaceutical startup developing nano-engineered, immune cell-targeted therapeutics, just announced the closing of an over-subscribed seed financing round totaling more than $2 million. The funding was led by Research Bridge Partners, co-led by ID Ventures, and included Michigan Rise Pre-Seed Fund III, BRCC of Western Michigan University, Ann Arbor Spark, Woodward Angels and other undisclosed investors. The funding will be used to move Asalyxa Bio’s lead development candidate, ASX-100, toward first-in-human clinical trials. We previously highlighted Asalyxa Bio’s early work on Cronicle as the company, led by Asalyxa Bio and holding company OrangeGrove Bio CEO Marc Appel, applied their technology to addressing Acute Respiratory Distress Syndrome caused by COVID-19 and other diseases.

20Fathoms Announces Virtual HealthSpark Digital and Telehealth Startup Accelerator (Deadline)
Announcements, Medical Tech, Networking

20Fathoms Announces Virtual HealthSpark Digital and Telehealth Startup Accelerator (Deadline)

Traverse City’s 20Fathoms just announced its new HealthSpark Accelerator for digital and telehealth startups, to be held virtually starting April 12, 2021, running through June 30. Preference is given to Michigan companies, but the cohort is not restricted to Michigan only so the virtual format means this could be a great opportunity for a startup from any location. “HealthSpark is a 12-week high-intensity program,” 20Fathoms Executive Director Lauren Bigelow tells Cronicle. “We have pulled experts from across the country who are both leaders and practitioners,” she says, so that startup founders gain experience and can network with leaders in their space who know what it is to build a digital or telehealth startup on the ground.

Workit Health Brings Telemedicine To Addiction Treatment
Medical Tech

Workit Health Brings Telemedicine To Addiction Treatment

If you’re seeking treatment for addiction, whether alcohol abuse or opioid or other substance abuse, there is now an option that brings the privacy and convenience of telemedicine to the entire process, from drug testing to medical followups to therapy. Workit Health is a medical tech startup out of Ann Arbor, Michigan, which recently closed on a Series A round of funding, and has drastically increased staff to handle the vast need for addiction recovery services in Michigan and beyond. The service recently expanded to California, New Jersey, Alaska, and Washington State.

A New Anti-Inflammatory Treatment Could Aid Sickest COVID Patients
Medical Tech, University of Michigan

A New Anti-Inflammatory Treatment Could Aid Sickest COVID Patients

During lockdown, Asalyxa Bio’s chief scientific officer Lola Eniola-Adefeso was one of the only people still working in Ann Arbor, where most work and scientific research was shut down to protect against the spread of COVID-19. Eniola-Adefeso was still working because she was one of a few scientists working on a treatment that could benefit the sickest COVID-19 patients, the ones who suffer from Acute Repiratory Distress Syndrome and cytokine storm. Eniola-Adefeso’s employer, new Ann Arbor biotech startup Asalyxa Bio, recently announced seed funding for its neutrophil targeting drug delivery technology to advance to first in-human trials next year. The tech can be used to target certain cells to treat Acute Repiratory Distress Syndrome, including the variety found in COVID-19 patients.

Tech on the Edge Biotech Companies Create New Cancer Treatment Options
Medical Tech, Networking

Tech on the Edge Biotech Companies Create New Cancer Treatment Options

Tech on the Edge is an Ann Arbor a2tech360 event that highlights biotech companies working on new technologies for applications from sustainable energy to medical technologies. This year during a2tech360’s tech week, the event highlighted companies from the edge of Ann Arbor’s tech scene including Ecovia Renewables, which is working on eco-friendly super-absorbent materials. Like many other companies involved in this year’s Tech on the Edge, Ecovia is hiring. Stabilux Biosciences also is looking for formulation chemists, people with biology background and more. Many of these companies are looking for scientists of various kinds, CTOs and CFOs, and management, all in the life sciences and biotech.

1 2 3
Our Sponsors
Ann Arbor SPARK, Ann Arbor business
Trek10 Sponsor Logo
Sponsor Cronicle Press
Sponsor Cronicle Press
Archives